Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Acerus Pharmaceuticals Corp.
DescriptionIntranasal gel form of dopamine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat hypomobility associated with late stage parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today